Title: Note 1. Basis of Presentation
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting.
De Minimis Rate Used: N
Rate Explanation: Such
expenditures are recognized following the cost principles contained in the Uniform Guidance,
wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Negative amounts shown on the Schedule represent adjustments or credits made in the normal
course of business to amounts reported as expenditures in prior years.
The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under
Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA)
which was approved by the U.S. Department of Health and Human Services on March 7, 2023.
The NICRA includes final indirect rates for the year ended December 31, 2021, and provisional
indirect rates for the Institute's use through the year ending December 31, 2024.
The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the
Federal award activity of Pacific Institute for Research and Evaluation and Affiliates (the Institute)
under programs of the Federal Government for the year ended December 31, 2023. Information
in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal
Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for Federal Awards (Uniform Guidance). The Schedule presents only a selected
portion of the operations of the Institute; accordingly, it is not intended to and does not present
the consolidated financial position, changes in net assets or cash flows of the Institute.
Title: Note 2. Summary of Significant Accounting Policies
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting.
De Minimis Rate Used: N
Rate Explanation: Such
expenditures are recognized following the cost principles contained in the Uniform Guidance,
wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Negative amounts shown on the Schedule represent adjustments or credits made in the normal
course of business to amounts reported as expenditures in prior years.
The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under
Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA)
which was approved by the U.S. Department of Health and Human Services on March 7, 2023.
The NICRA includes final indirect rates for the year ended December 31, 2021, and provisional
indirect rates for the Institute's use through the year ending December 31, 2024.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such
expenditures are recognized following the cost principles contained in the Uniform Guidance,
wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Negative amounts shown on the Schedule represent adjustments or credits made in the normal
course of business to amounts reported as expenditures in prior years.
The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under
Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA)
which was approved by the U.S. Department of Health and Human Services on March 7, 2023.
The NICRA includes final indirect rates for the year ended December 31, 2021, and provisional
indirect rates for the Institute's use through the year ending December 31, 2024.
Title: Note 3. Assistance Listing Numbers
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting.
De Minimis Rate Used: N
Rate Explanation: Such
expenditures are recognized following the cost principles contained in the Uniform Guidance,
wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Negative amounts shown on the Schedule represent adjustments or credits made in the normal
course of business to amounts reported as expenditures in prior years.
The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under
Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA)
which was approved by the U.S. Department of Health and Human Services on March 7, 2023.
The NICRA includes final indirect rates for the year ended December 31, 2021, and provisional
indirect rates for the Institute's use through the year ending December 31, 2024.
When assistance listing numbers are not available, federal awards are classified in the Schedule
based on the U.S. agency prefix and are grouped for major program determination as provided
by the Uniform Guidance.
Title: Note 4. Reconciliation of Schedule of Expenditures of Federal Awards to Support
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting.
De Minimis Rate Used: N
Rate Explanation: Such
expenditures are recognized following the cost principles contained in the Uniform Guidance,
wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Negative amounts shown on the Schedule represent adjustments or credits made in the normal
course of business to amounts reported as expenditures in prior years.
The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under
Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA)
which was approved by the U.S. Department of Health and Human Services on March 7, 2023.
The NICRA includes final indirect rates for the year ended December 31, 2021, and provisional
indirect rates for the Institute's use through the year ending December 31, 2024.
Some of the Institute's federal awards provide for both the recovery of allowable costs plus a fee
above and beyond the allowable costs. Therefore, the total federal expenditures in the Schedule
do not agree to the support from federal awards reported in the Consolidated Statement of
Activities.
The following table reconciles the expenditures in the Schedule to total support from federal
awards for the year ended December 31, 2023:
Schedule of Expenditures of Federal Awards $10,672,250
Additional support from federal awards in excess of expenditures 443,785
TOTAL SUPPORT FROM FEDERAL AWARDS $11,116,035